Table 1.
Antigen/APC | Advantage | Disadvantage |
---|---|---|
Whole virus/viral lysate | Potent antigen | Live virus, lengthy production time |
Whole proteins | Readily available | Less potent antigen |
Viral vectors | Reproducible | Lengthy production time |
Peptide/peptide mixtures | Reproducible, standardized, readily available | Need identified immunodominant epitopes |
Dendritic cells | Potent stimulators | Limited cell numbers, difficult to isolate |
Monocytes | Easily isolated | Reduced potency |
B cells | More robust numbers | Reduced generation of Tmem (26), increased production time |
PHA blasts | Reduced production time, easily expanded | Moderate potency |
Artificial APC | Easily expanded and maintained; effective costimulation | Varying efficacy |